These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 15213839

  • 1. Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
    Turpie AG, Norris TM.
    Thromb Haemost; 2004 Jul; 92(1):3-12. PubMed ID: 15213839
    [Abstract] [Full Text] [Related]

  • 2. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF, Kher A.
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [Abstract] [Full Text] [Related]

  • 3. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S.
    Semin Thromb Hemost; 1999 May; 25 Suppl 3():101-5. PubMed ID: 10549724
    [Abstract] [Full Text] [Related]

  • 4. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK.
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [Abstract] [Full Text] [Related]

  • 5. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG.
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [Abstract] [Full Text] [Related]

  • 6. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 7. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
    McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ.
    Am J Manag Care; 2004 Sep; 10(9):632-42. PubMed ID: 15515996
    [Abstract] [Full Text] [Related]

  • 8. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J, Dulícek P, Penka M, Malý R, Gumulec J.
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [Abstract] [Full Text] [Related]

  • 9. Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Offord R, Lloyd AC, Anderson P, Bearne A.
    Pharm World Sci; 2004 Aug; 26(4):214-20. PubMed ID: 15446778
    [Abstract] [Full Text] [Related]

  • 10. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.
    Chapman TM, Goa KL.
    Drugs; 2003 Aug; 63(21):2357-77. PubMed ID: 14524738
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 12. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients.
    Spyropoulos AC.
    Chest; 2005 Aug; 128(2):958-69. PubMed ID: 16100192
    [Abstract] [Full Text] [Related]

  • 13. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 14. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
    Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H.
    Br J Surg; 2001 Jul 30; 88(7):913-30. PubMed ID: 11442521
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D.
    Br J Surg; 2004 Aug 30; 91(8):965-74. PubMed ID: 15286956
    [Abstract] [Full Text] [Related]

  • 16. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
    Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W, Cohen E, Zukor D.
    Chest; 2005 Nov 30; 128(5):3364-71. PubMed ID: 16304285
    [Abstract] [Full Text] [Related]

  • 17. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.
    Deitelzweig SB, Vanscoy GJ, Niccolai CS, Rihn TL.
    Ann Pharmacother; 2003 Mar 30; 37(3):402-11. PubMed ID: 12639173
    [Abstract] [Full Text] [Related]

  • 18. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
    de Lissovoy G, Subedi P.
    Am J Manag Care; 2002 Dec 30; 8(12):1082-8. PubMed ID: 12500884
    [Abstract] [Full Text] [Related]

  • 19. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH, Muntz J.
    Clin Ther; 2009 Jun 30; 31(6):1129-41. PubMed ID: 19695383
    [Abstract] [Full Text] [Related]

  • 20. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA, Arcelus J, Sehgal LR, Cohen EB, Reyna JJ.
    Int Angiol; 2002 Mar 30; 21(1):78-85. PubMed ID: 11941278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.